-
Featured
Sex-specific Genetic Effects Across Neuropsychiatric and Behavioral Traits Identified for the First Time
Jill M. Goldstein, PhD, and Jordan W. Smoller, MD, ScD, of the Department of Psychiatry, and colleagues have reported the first modest evidence of sex-dependent autosomal genetic effects across neuropsychiatric and behavioral traits.
-
Featured
Longitudinal Data in Electronic Health Records Can Be Used to Predict Risk of Suicide
Previous research has shown that diagnostic codes routinely collected in electronic health records can help predict domestic abuse an average of two years in advance. Could EHR systems also be used to predict suicidal behavior?
-
Psychiatric Disorders Not Associated With Incidental Findings in Medically Actionable Genes
Using the same approach as in a phenome-wide association study, Yen-Chen A. Feng, ScD, Jordan W. Smoller, MD, ScD, and colleagues systematically evaluated data on 15,181 individuals and did not identify any psychiatric manifestations of rare variations in medically actionable genes.
-
Cannabis Use Disorder Can Develop Soon After a Medical Marijuana Card Is Obtained
In a clinical trial at Massachusetts General Hospital, patients who obtained a medical marijuana card for pain, anxiety, or depression had almost three times higher risk of cannabis use disorder than those whose card was delayed, and they had no major improvement in symptoms—but cannabis helped patients with insomnia.
-
Help-seeking by Older Adults for Mental Health Symptoms Varies by Race/Ethnicity
With data collected at organizations and clinics serving low-income older people, Margarita Alegría, PhD, Liao Zhang, MD, PsyaD, and team found no difference between Black and white adults in mental health service use. Still, white people were more likely than older adults of color to seek care at lower levels of need.
-
Editorial: Embracing a Biopsychosocial Approach to Brain Health
Ryan A. Mace, PhD, Victoria A. Grunberg, PhD, and Ana-Maria Vranceanu, PhD, urge interdisciplinary colleagues to embrace a biopsychosocial and developmental concept of brain health, shifting focus from treating symptoms to preventing neurological and psychiatric illnesses and promoting optimal brain functioning.
Psychiatry Contributors
-
David Mischoulon, MD, PhD
Director, Depression Clinical and Research Program
Recent Article
Mindfulness-based Cognitive Therapy Shows Promise for Treating Depression in Chronically Ill Patients
-
Eve Valera, PhD
Researcher, Athinoula A. Martinos Center for Biomedical Imaging
Recent Article
Traumatic Brain Injuries Caused by Intimate Partner Violence
-
Jodi Gilman, PhD
Director of Neuroscience, Center for Addiction Medicine, Massachusetts General Hospital
Recent Article
Cannabis Use Disorder Can Develop Soon After a Medical Marijuana Card Is Obtained
-
Jordan W. Smoller, MD, ScD
Associate Chief for Research, Department of Psychiatry, Massachusetts General Hospital, Director, Psychiatric and Neurodevelopmental Genetics Unit, Professor of Psychiatry at Harvard Medical School and Professor in the Department of Epidemiology at the Harvard School of Public Health
Recent Article
Psychiatric Disorders Not Associated With Incidental Findings in Medically Actionable Genes
-
Maurizio Fava, MD
Psychiatrist-In-Chief; Director, Division of Clinical Research of the MGH Research Institute, Executive Director, Clinical Trials Network and Institute (CTNI), Massachusetts General Hospital, Associate Dean for Clinical & Translational Research, Slater Family Professor of Psychiatry, Harvard Medical School
Recent Article
Esmethadone Safe and Tolerable in Phase 2a Trial in Major Depressive Disorder
Neuroscience Care at Mass General
Through a combination of unmatched expertise, creativity and compassion, Mass General Neuroscience relentlessly advances the fields of Neurosurgery, Neurology and Psychiatry to unleash our patients’ potential.